Multi-omics data integration identifies novel biomarkers and patient subgroups in inflammatory bowel disease

Abstract

Our work unveiled potential biomarkers to discriminate between CD and UC and to stratify each population into well-defined subgroups, offering promising avenues for the application of precision medicine strategies.